Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus

https://doi.org/10.1016/j.jaut.2006.01.001Get rights and content

Abstract

We investigated the familial aggregation of autoimmune diseases (AIDs) among first-degree relatives (FDR) of patients with type 1 diabetes mellitus (T1D). Relatives of 98 T1D patients defined according to the guidelines diagnosis of the American Diabetes Association and 113 matched controls without any AID, were interviewed using a questionnaire that sought information about demographic and medical characteristics including a list of 18 AIDs. Genetic analysis was performed using the program ASSOC and by calculating recurrent risk ratios. In cases, 25.5% of the families had at least one member having an AID, while in controls there were 9% (odds ratio [OR]: 3.96, 95% confidence interval [CI] = 1.74–9.0, p = 0.0006). An AID was registered in 8.3% of 312 FDR of patients as compared with 2.4% of 362 FDR in controls (OR: 3.56, 95% CI = 1.64–7.73, p = 0.0008). The most frequent AIDs registered in FDR of cases were autoimmune thyroid disease (AITD) and T1D, which disclosed coefficients of aggregation. These results indicate that AIDs cluster within families of T1D patients adding further evidence to consider that clinically different autoimmune phenotypes may share common susceptibility gene variants, which may act pleiotropically as risk factors for autoimmunity.

Introduction

Autoimmune diseases (AIDs) are chronic conditions initiated by a loss of immunological tolerance to self-antigens. The chronic nature of many of these diseases results in a significant impact in terms of medical care utilization, direct and indirect economic costs, and quality of life. The estimated incidence of AIDs is about 90 per 100,000 person-years and their prevalence is about 3% of the population [1]. Almost all AIDs disproportionately affect middle-aged women, being one of the leading causes of death among this group of patients. The older the patient, the lower the male:female ratio becomes [1].

Although the etiology of AIDs is unknown, several factors are involved in the development of these diseases, including genetic and environmental factors [2], [3]. Population studies have established that each population holds a mutational pool, in which most mutations individually (i.e. polymorphisms) will have mild effects; if not undetectable, but in combination with other alleles would favor or avoid autoimmune phenomena. Such interplay within genetic variants will generate a change in the measurable risk of developing an autoimmune phenotype. This characteristic is the main reason why AIDs are not inherited in a classical simple Mendelian way, but instead have a complex or yet unknown mode of inheritance [3]. Genetic contribution to AIDs is supported by the high rates of concordance, ranging from 15% to 60%, and by high recurrent risk ratios (λR) [4].

There is evidence indicating that some AIDs will concentrate within families. This includes not only cases of a single type of AID (several members having the same trait) appearing among siblings, twins and relatives of patients [5], [6], [7], [8], but also several different ones (several family members with diverse AIDs) appearing [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], thus indicating that autoimmune phenotypes could represent pleiotropic outcomes of non-specific disease genes that underlie similar immunogenetic mechanisms. This common origin hypothesis for different AIDs is also supported by results of genome-wide scans showing that several loci may overlap in different AIDs [20], [21], and by microarray expression profile studies disclosing a similar pattern of gene expression in different AIDs [22], [23]. Finally, the multiple autoimmune syndrome, characterized by the presence of three or more AIDs in a single individual [24], is a clear example of how diverse phenotypes may be related to a single genotype.

Type 1 diabetes mellitus (T1D) is an organ-specific AID resulting from the damage of insulin-producing pancreatic β cells. This disease constitutes the earliest-onset AID, with a male:female ratio of 1:1 [25]. Similar to other AIDs, T1D is an immune-mediated disease that develops in genetically susceptible individuals, in whom one or more additional AIDs may coexist, autoimmune thyroid diseases (AITD) (i.e. Graves' disease or Hashimoto's thyroiditis) and celiac disease (CD) being the most prevalent [26], [27], [28]. First-degree relatives (FDR) are more predisposed to develop T1D and to have a higher proportion of autoantibodies compared to the general population [25]. Considering the interaction between AIDs that is summarized above and the fact that there is growing evidence supporting a common genetic origin for these diseases, the familial aggregation of autoimmunity within first degree relatives (FDR) of T1D patients was examined.

Section snippets

Demographics of T1D patients and healthy individuals

Cases were children with T1D all of whom fulfilled the diagnostic classification criteria proposed by the American Diabetes Association (ADA) [29] and who belonged to our T1D cohort [30]. Their information on demographics and cumulative clinical manifestations over the course of disease were obtained by both chart review and discussion with the patient and was collected in a standard data collection form. A total of 98 patients with T1D were evaluated. Controls were 113 healthy children without

Diverse autoimmune diseases in pedigrees of T1D patient and controls

In this study 98 T1D patients were examined. In the families cases, 25 (25.5%) presented at least one FDR having an AID compared with 9 (8%) in control families (OR: 3.96, 95% CI: 1.75–9; p = 0.0006) (Table 1). There were not differences within gender, with a female: male ratio of 1:1.

Specific AIDs in FDR of T1D patients and healthy individuals are shown in Table 2. There were a total of 26 (8.3%) AIDs among the 312 FDR in cases compared with 9 (2.4%) AIDs among 362 FDR in controls (OR: 3.56, 95%

Discussion

These results indicate familial clustering of AIDs in patients with T1D in our population, and are consistent with previous results showing familial autoimmunity in other AIDs such as rheumatoid arthritis (RA) [9], systemic lupus erythematosus (SLE) [10], [11], primary Sjögren's syndrome [12], [13], polymyositis [14], juvenile RA [15], multiple sclerosis [16], vitiligo [17], and pemphigus [18].

Tait et al. [19] examined the presence of AIDs in British family members of patients with T1D.

Acknowledgments

We thank all the patients and participants of this study. Some of the results of this study were obtained by using the program package S.A.G.E., which is supported by a U.S. Public Health Service Resource Grant (RR03655) from the National Center for Research Resources. We also thank the two anonymous reviewers of this paper for their important comments.

References (43)

  • W.B. Bias et al.

    Evidence that autoimmunity in man is a Mendelian dominant trait

    Am J Hum Genet

    (1986)
  • A. Wandstrat et al.

    The genetics of complex autoimmune diseases: non-MHC susceptibility genes

    Nat Immunol

    (2001)
  • K.M. Houghton et al.

    Primary Sjogren's syndrome in dizygotic adolescent twins: one case with lymphocytic interstitial pneumonia

    J Rheumatol

    (2005)
  • M. Michel et al.

    Familial lupus erythematosus. Clinical and immunologic features of 125 multiplex families

    Medicine (Baltimore)

    (2001)
  • J.P. Lin et al.

    Familial clustering of rheumatoid arthritis with other autoimmune diseases

    Hum Genet

    (1998)
  • R. Priori et al.

    Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a casecontrol study

    Lupus

    (2003)
  • J.D. Reveille et al.

    Familial systemic lupus erythematosus: immunogenetic studies in eight families

    Medicine (Baltimore)

    (1983)
  • J.D. Reveille et al.

    Primary Sjögren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds

    Ann Intern Med

    (1984)
  • J.M. Anaya et al.

    Familial clustering of autoimmune diseases in patients with primary Sjögren's syndrome

    Arthritis Rheum

    (2005)
  • R.L. Ginn et al.

    Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases

    Arthritis Rheum

    (1998)
  • S. Prahalad et al.

    Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis

    Arthritis Rheum

    (2002)
  • Cited by (0)

    View full text